tiprankstipranks
Circle8 Group (CIRC)
NASDAQ:CIRC
US Market
Want to see CIRC full AI Analyst Report?

Circle8 Group (CIRC) AI Stock Analysis

67 Followers

Top Page

CIRC

Circle8 Group

(NASDAQ:CIRC)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 5.2)
Rating:44Neutral
Price Target:
$0.75
▼(-83.17% Downside)
Action:Reiterated
Date:07/10/26
The score is primarily weighed down by weak financial performance—ongoing losses, negative free cash flow, and high leverage relative to equity—despite strong recent revenue growth. Technicals also reflect a broader downtrend (below key moving averages with negative MACD), with only a modest offset from near-term oversold readings. Valuation provides limited support because the negative P/E reflects unprofitable operations and no dividend yield is available.
Positive Factors
Revenue Growth
Sustained double-digit TTM revenue growth indicates durable demand and expanding market traction. Over 2-6 months this growth can provide scale benefits, support reinvestment in R&D or commercial expansion, and form the revenue base needed for future margin recovery if cost discipline continues.
Negative Factors
Negative Cash Flow
Persistent negative operating and free cash flow is a structural concern: it forces ongoing external financing, increases dilution or leverage risk, and constrains the company’s ability to invest in commercialization or R&D. Without sustained cash generation, growth can be capital constrained long-term.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained double-digit TTM revenue growth indicates durable demand and expanding market traction. Over 2-6 months this growth can provide scale benefits, support reinvestment in R&D or commercial expansion, and form the revenue base needed for future margin recovery if cost discipline continues.
Read all positive factors

Circle8 Group (CIRC) vs. SPDR S&P 500 ETF (SPY)

Circle8 Group Business Overview & Revenue Model

Company Description
Circle8 Group is a global technology and workforce solutions company serving enterprise, government, and multinational organizations across North America and Europe. The company provides Technology Consulting, Technology Solutions, Managed Service...
How the Company Makes Money
null...

Circle8 Group Financial Statement Overview

Summary
Despite strong TTM revenue growth (+33.7%), the business remains financially weak: low gross margin (~10.6%), operating losses (EBIT margin ~-11.5%) and net losses (net margin ~-13.6%) persist. Cash flow is negative (TTM operating cash flow and free cash flow about -$28.9M), and the balance sheet is pressured by high leverage (total debt ~$312.5M vs. equity ~$64.3M) and historically volatile equity.
Income Statement
22
Negative
Balance Sheet
18
Very Negative
Cash Flow
20
Very Negative
Breakdown
Income Statement
Total Revenue
Gross Profit
EBITDA
Net Income
Balance Sheet
Total Assets
Cash, Cash Equivalents and Short-Term Investments
Total Debt
Total Liabilities
Stockholders Equity
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Circle8 Group Technical Analysis

Technical Analysis Sentiment
Negative
Last Price4.45
Price Trends
50DMA
1.03
Negative
100DMA
1.93
Negative
200DMA
2.23
Negative
Market Momentum
MACD
-0.08
Negative
RSI
45.57
Neutral
STOCH
45.22
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CIRC, the sentiment is Negative. The current price of 4.45 is above the 20-day moving average (MA) of 0.84, above the 50-day MA of 1.03, and above the 200-day MA of 2.23, indicating a bearish trend. The MACD of -0.08 indicates Negative momentum. The RSI at 45.57 is Neutral, neither overbought nor oversold. The STOCH value of 45.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CIRC.

Circle8 Group Risk Analysis

Circle8 Group disclosed 48 risk factors in its most recent earnings report. Circle8 Group reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Circle8 Group Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
56
Neutral
$307.79M-4.55-46.74%167.42%-22.94%
54
Neutral
$793.29M-9.95-55.89%-52.94%59.88%
50
Neutral
$106.06M-5.20-113.53%20.55%-4.63%
47
Neutral
$112.73M-164.68%69.52%58.15%
44
Neutral
$69.48M-0.68274.33%27.45%82.80%
42
Neutral
$21.72M-0.62402.97%17.42%42.75%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CIRC
Circle8 Group
0.72
-1.05
-59.44%
ACRS
Aclaris Therapeutics
5.69
4.07
251.23%
MDXH
MDxHealth
0.42
-2.00
-82.52%
STIM
Neuronetics
1.88
-2.34
-55.45%
XGN
Exagen
4.86
-2.08
-29.97%
PRE
Prenetics Group
22.06
13.94
171.61%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 10, 2026